Abstract
Alzheimer disease (AD) is one of the most common and serious neurodegenerative disorders in humans. For this reason, the search for new anti-AD treatments is a very active area. Only few biological receptors associated with AD have been well studied. The efficacy of the current drugs is limited by the fact that they inhibit only one target like protein. Thus, the rational design of new drug candidates as versatile inhibitors for different proteins associated with AD, constitutes a major goal. With the aim to overcome this problem, we developed here the first fragment-based approach by exploring quantitative-structure-activity relationships (QSAR). The principal purpose was the in silico design of multitarget (mt) inhibitors against five proteins associated with AD. Our approach was focused on the construction of an mt- QSAR discriminant model using a large and heterogeneous database of compounds and substructural descriptors, which permitted the simultaneous classification and prediction of inhibitors against five proteins associated with AD. The model correctly classified more than 90% of active and inactive compounds in both, training and prediction series. As principal advantage, this mt-QSAR discriminant model was used for the automatic and fast extraction of fragments responsible for the inhibitory activity against the five proteins under study, and new molecular entities were suggested as possible versatile inhibitors for these proteins.
Keywords: Anti-AD agents, fragment, linear discriminant analysis, mt-inhibitors, QSAR, quantitative contributions
Current Alzheimer Research
Title:Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors
Volume: 10 Issue: 2
Author(s): Alejandro Speck-Planche, Valeria V. Kleandrova, Feng Luan and M. Natalia D. S. Cordeiro
Affiliation:
Keywords: Anti-AD agents, fragment, linear discriminant analysis, mt-inhibitors, QSAR, quantitative contributions
Abstract: Alzheimer disease (AD) is one of the most common and serious neurodegenerative disorders in humans. For this reason, the search for new anti-AD treatments is a very active area. Only few biological receptors associated with AD have been well studied. The efficacy of the current drugs is limited by the fact that they inhibit only one target like protein. Thus, the rational design of new drug candidates as versatile inhibitors for different proteins associated with AD, constitutes a major goal. With the aim to overcome this problem, we developed here the first fragment-based approach by exploring quantitative-structure-activity relationships (QSAR). The principal purpose was the in silico design of multitarget (mt) inhibitors against five proteins associated with AD. Our approach was focused on the construction of an mt- QSAR discriminant model using a large and heterogeneous database of compounds and substructural descriptors, which permitted the simultaneous classification and prediction of inhibitors against five proteins associated with AD. The model correctly classified more than 90% of active and inactive compounds in both, training and prediction series. As principal advantage, this mt-QSAR discriminant model was used for the automatic and fast extraction of fragments responsible for the inhibitory activity against the five proteins under study, and new molecular entities were suggested as possible versatile inhibitors for these proteins.
Export Options
About this article
Cite this article as:
Speck-Planche Alejandro, V. Kleandrova Valeria, Luan Feng and Natalia D. S. Cordeiro M., Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors, Current Alzheimer Research 2013; 10 (2) . https://dx.doi.org/10.2174/1567205011310020001
DOI https://dx.doi.org/10.2174/1567205011310020001 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytokines in HIV-Infection - Inflammatory Damage or Therapeutic Potential?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Spatial Correlations between the Vacuolation, Prion Protein (PrPsc) Deposits and the Cerebral Blood Vessels in Sporadic Creutzfeldt-Jakob Disease
Current Neurovascular Research Simplified Computational Methods for the Analysis of Protein Flexibility
Current Protein & Peptide Science Retinal Degenerations: From Cell Signaling to Cell Therapy; Pre-Clinical and Clinical Issues
Current Gene Therapy Extraction, Characterization and In Vivo Neuromodulatory Activity of Phytosterols from Microalga Dunaliella Tertiolecta
Current Medicinal Chemistry C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets JNK Signalling: A Possible Target to Prevent Neurodegeneration
Current Pharmaceutical Design Acetate Suppresses Lipopolysaccharide-stimulated Nitric Oxide Production in Primary Rat Microglia but not in BV-2 Microglia Cells
Current Molecular Pharmacology Definition of Genes and Paths Involved in Alzheimers Disease: Using Gene Expression Profiles and Chemical Genetics at the Mouse Brain Level
Current Genomics Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)
Current Medicinal Chemistry Ethanolamine: A Potential Promoiety with Additional Effects on the Brain
CNS & Neurological Disorders - Drug Targets Heat Shock Response Regulates Insulin Sensitivity and Glucose Homeostasis: Pathophysiological Impact and Therapeutic Potential
Current Diabetes Reviews Oral Supplements of <i>Ginkgo biloba</i> Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats
Current Pharmaceutical Biotechnology Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology Potential of Photobiomodulation to Induce Differentiation of Adipose- Derived Mesenchymal Stem Cells into Neural Cells
Current Stem Cell Research & Therapy Polymerase Delta in Eukaryotes: How is It Transiently Exchanged with Specialized DNA Polymerases During Translesion DNA Synthesis?
Current Protein & Peptide Science The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets The Role of Immune and Inflammatory Mechanisms in ALS
Current Molecular Medicine Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
Current Neuropharmacology